Literature DB >> 17179631

Imiquimod.

Kruti S Jobanputra1, Aruna V Rajpal, N G Nagpur.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 17179631     DOI: 10.4103/0378-6323.29352

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN: 0378-6323            Impact factor:   2.545


× No keyword cloud information.
  7 in total

1.  A Comparative Study of Intralesional Vitamin D3, Measles Mumps Rubella Vaccine, and Tuberculin Purified Protein Derivative in the Treatment of Recalcitrant Warts: An Approach to Solve a Therapeutic Conundrum.

Authors:  Srishti Jain; Yogesh S Marfatia
Journal:  J Clin Aesthet Dermatol       Date:  2021-11

2.  Pigmented basal cell carcinoma successfully treated with 5% Imiquimod cream.

Authors:  Vandana Mehta; C Balachandran
Journal:  Indian J Dermatol       Date:  2008       Impact factor: 1.494

3.  Effects of imiquimod and low-intensity laser (λ660 nm) in chemically induced oral carcinomas in hamster buccal pouch mucosa.

Authors:  Juliana S de C Monteiro; Susana C P S de Oliveira; João Alves Reis Júnior; Clarissa Araújo Silva Gurgel; Suzana C O Machado de Souza; Antônio Luiz Barbosa Pinheiro; Jean Nunes dos Santos
Journal:  Lasers Med Sci       Date:  2012-09-01       Impact factor: 3.161

4.  Facial Basal Cell Carcinoma Treated with Topical 5% Imiquimod Cream with Dermoscopic Evaluation.

Authors:  Archana Singal; Deepashree Daulatabad; Deepika Pandhi; V K Arora
Journal:  J Cutan Aesthet Surg       Date:  2016 Apr-Jun

5.  Dermatoscopy-guided therapy of pigmented basal cell carcinoma with imiquimod.

Authors:  Husein Husein-ElAhmed; Maria Antonia Fernandez-Pugnaire
Journal:  An Bras Dermatol       Date:  2016 Nov-Dec       Impact factor: 1.896

Review 6.  Imiquimod - Its role in the treatment of cutaneous malignancies.

Authors:  Aditya Kumar Bubna
Journal:  Indian J Pharmacol       Date:  2015 Jul-Aug       Impact factor: 1.200

Review 7.  Novel medical strategies combating nonmelanoma skin cancer.

Authors:  Prasan R Bhandari; Varadraj V Pai
Journal:  Indian J Dermatol       Date:  2014-11       Impact factor: 1.494

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.